Hinge Health (HNGE) sees Bessemer funds sell 26,226 shares

Q: How many HNGE shares did each Bessemer fund sell in this Form 4?

Bessemer Venture Partners X L.P. sold 13,527 shares and Bessemer Venture Partners X Institutional L.P. sold 12,699 shares of Hinge Health, Inc. Class A Common Stock, according to the Form 4 footnotes.

Q: At what price were the HNGE shares sold by the Bessemer funds?

The Bessemer funds sold Hinge Health, Inc. shares at a weighted average price of $90.05 per share, in multiple transactions at prices ranging from $90.00 to $90.44.

Q: Did Robinson Elliott personally sell HNGE shares in this filing?

No. The sales were made by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P.. Robinson Elliott has an indirect, passive economic interest and disclaims beneficial ownership except for any pecuniary interest.

Q: Was the HNGE Form 4 filed under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not checked, and the footnotes do not state that the reported sales were made pursuant to a Rule 10b5-1 trading plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) had a Form 4 filed for reporting person Robinson Elliott in connection with sales of its Class A Common Stock by affiliated investment funds. On August 19, 2026, Bessemer Venture Partners X L.P. sold 13,527 shares and Bessemer Venture Partners X Institutional L.P. sold 12,699 shares at a weighted average price of $90.05 per share in multiple transactions between $90.00 and $90.44. Elliott is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the Bessemer Funds and expressly disclaims beneficial ownership of these securities except to the extent of any pecuniary interest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Robinson Elliott

Role Director

Sold 0 shs ($0.00)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock ^{F1, F2}	0	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 0 shares (Indirect, See footnote)

Footnotes (2)

F1. On August 19, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 13,527 and 12,699 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $90.05. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

Key Figures

Shares sold by BVP X L.P.: 13,527 shares Shares sold by BVP X Institutional L.P.: 12,699 shares Weighted average sale price: $90.05 per share +2 more

5 metrics

Shares sold by BVP X L.P. 13,527 shares Class A Common Stock sold on August 19, 2026

Shares sold by BVP X Institutional L.P. 12,699 shares Class A Common Stock sold on August 19, 2026

Weighted average sale price $90.05 per share Sales of Class A Common Stock by Bessemer Funds

Sale price range $90.00 to $90.44 per share Range of prices for the multiple transactions on August 19, 2026

Total shares sold by Bessemer Funds 26,226 shares Combined sales by BVP X and BVP X Institutional on August 19, 2026

Key Terms

weighted average price, multiple transactions, indirect, passive economic interest, beneficial ownership, +1 more

5 terms

weighted average price financial

"sold 13,527 and 12,699 shares ... at a weighted average price of $90.05"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

multiple transactions financial

"These shares were sold in multiple transactions at prices ranging"

indirect, passive economic interest financial

"has an indirect, passive economic interest in the shares held"

beneficial ownership regulatory

"disclaims beneficial ownership of the securities held by the Bessemer Funds"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of his pecuniary interest, if any, in such securities"

FAQ

What insider activity was reported for HNGE on August 19, 2026?

Affiliated funds of Bessemer Venture Partners reported sales of 26,226 shares of Hinge Health, Inc. Class A Common Stock on August 19, 2026, executed by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P.

How many HNGE shares did each Bessemer fund sell in this Form 4?

Bessemer Venture Partners X L.P. sold 13,527 shares and Bessemer Venture Partners X Institutional L.P. sold 12,699 shares of Hinge Health, Inc. Class A Common Stock, according to the Form 4 footnotes.

At what price were the HNGE shares sold by the Bessemer funds?

The Bessemer funds sold Hinge Health, Inc. shares at a weighted average price of $90.05 per share, in multiple transactions at prices ranging from $90.00 to $90.44.

Did Robinson Elliott personally sell HNGE shares in this filing?

No. The sales were made by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P.. Robinson Elliott has an indirect, passive economic interest and disclaims beneficial ownership except for any pecuniary interest.

Was the HNGE Form 4 filed under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not checked, and the footnotes do not state that the reported sales were made pursuant to a Rule 10b5-1 trading plan.

What kind of ownership interest does Robinson Elliott have in the HNGE shares?

Robinson Elliott has an indirect, passive economic interest in the Hinge Health, Inc. shares held by the Bessemer Funds through interests in Deer X & Co. L.P. and other limited partnership interests, and he disclaims beneficial ownership except for any pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/21/2026 - 05:19 PM Accepted by SEC EDGAR 08/21/2026 - 05:19 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robinson Elliott

(Last)

(First)

(Middle)

C/O BESSEMER VENTURE PARTNERS

1865 PALMER AVENUE, SUITE 104

(Street)

LARCHMONT

NEW YORK

10538

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	08/19/2026		S		0⁽¹⁾	D	$0	0	I	See footnote⁽¹⁾⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On August 19, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 13,527 and 12,699 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $90.05. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

	/s/ Augie Wilkinson, Attorney-in-Fact	08/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR